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Background: Prevalence of COPD is increasing worldwide, and there is need for regularly up-
dated estimates of COPD prevalence and risk factors.
Methods: In the Norwegian Hordaland County Cohort Study (HCCS), 1664 subjects aged 35
e90 yrs answered questionnaires and performed spirometry in 2003e05. We estimated COPD
prevalence and analysed risk factors for COPD with logistic regression.
Results: In a previous study phase, prevalence of GOLD-defined COPD was 7%. Eight years later,
corresponding prevalence was 14%. Seventy % of the subjects experienced respiratory symp-
toms. Only 1 out of 4 had a physician’s diagnosis. Significant risk factors for COPD were sex,
age, smoking habits and pack-years. Men had 1.7 (OR, 95% CI 1.2, 2.3) higher odds for COPD
than women. Subjects above 65 yrs had 10.3 (OR, 95% CI 6.4, 16.5) times higher odds for COPD
than subjects below 40 yrs. Heavy smokers had 4.2 (OR, 95% CI 2.6, 6.7) times higher odds for
COPD than subjects with <10 pack-years. When compared with the previous study phase, age
and smoking status had roughly the same associations with COPD prevalence. Educational level
and male gender, on the other hand, had less effect on COPD prevalence in 2005 than in 1997,
while pack years were more important in 2005 than in 1997.
Conclusions: Prevalence of GOLD defined COPD has increased from 7% to 14% in nine years.
Although the risk factors remain the same, the strength of associations vary. There is still sub-
stantial under diagnosis in COPD, and better disease awareness and diagnostic routines are
needed.
ª 2013 Elsevier Ltd. All rights reserved.linical Research, Haukeland University Hospital, 5021 Bergen, Norway. Tel.: þ47 55 97 07 98; fax: þ47
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1038 M. Waatevik et al.Introduction Material and methodsFigure 1 Flow chart of invited and participants in the Hor-
daland County cohort from first study phase in 1985 to last
study phase in 2003e05.The public has become increasingly aware of chronic
obstructive pulmonary disease (COPD) during recent years.
At the same time, COPD has become increasingly more
prevalent across the world, and it is now estimated to be
the fourth leading cause of death worldwide.1
COPD is a progressive disease characterized by persis-
tent airflow limitation and an enhanced inflammatory
response in the airways and the lungs to noxious particles or
gases.2 The most common symptoms are dyspnea, chronic
cough and chronic sputum production. Spirometry is
required to diagnose COPD patients according to interna-
tional guidelines.2,3 The disease usually exhibits a slow
progression and COPD patients consequently often wait for
many years before seeking medical advice, dismissing early
symptoms as smokers cough, lack of general fitness, or
simply part of the ageing process. As a result, the disease is
widely under diagnosed, despite the large prevalence of
symptoms affecting a substantial number of people in their
everyday activities.4e7
Active cigarette smoking is by far the most important
cause of this disease. But also passive smoking, occupa-
tional exposure to airborne agents, air pollution and poor
indoor climate are important COPD risk factors.2,8e11 In
addition, other risk factors that have a more complex as-
sociation with disease development and prognosis than
direct inhalation are of relevance e such as socioeconomic
status, nutrition, physical activity and mental well-
being.12e18
International reports and guidelines unanimously state
that the prevalence of COPD is increasing worldwide.2,19
Thus, there is need for regularly updates of prevalence
estimates in general populations to keep track of this
worrying development. The COPD prevalence estimates
that have been used in Norway for official reports and
health care planning are based on a general population
that was examined in 1996e97.20 Based on the 1996 sit-
uation, COPD prevalence was estimated to be 7% in
Norwegian adults, ranging from less than 3% in never-
smokers to more than 17% in ever-smokers who had
smoked more than 20 pack years. The 1996 prevalence
was based on COPD defined according to the Global
Initiative of Chronic Obstructive Lung Disease (GOLD) as a
fixed ratio of forced expiratory volume in one second
(FEV1) over forced vital capacity (FVC) < 0.7. Although
the GOLD guidelines still advocate the fixed ratio for
practical reasons, it is a fact that the FEV1/FVC declines
with age and thus risks over diagnosing COPD in the
elderly. Consequently the definition of COPD as a ratio
less than lower limit of normal has been recommended as
a replacement for the fixed ratio, among others by the
American Thoracic Society and European Respiratory
Society.21e23
The aim of the present study was to update prevalence
estimates of COPD in a general adult population in Norway,
and to examine differences in both disease prevalence and
risk factor associations across time. In addition, we wanted
to assess the degree of under diagnosis among COPD sub-
jects, and the presence of respiratory symptoms in
spirometry-defined COPD cases.Study population
This study is based on the second follow-up survey in the
Hordaland County Cohort study (HCCS) in 2003e2005
(Fig. 1). Initially, the HCCS comprised 3181 participants
from Bergen and 11 surrounding municipalities in 1985, of
whom 2358 performed acceptable spirometry in the first
follow-up in 1996e97 (74%).24 Of these, 2250 subjects who
still lived in Hordaland County in 2003e05 were invited to
the second follow-up. Altogether 74% (n Z 1664), aged
35e90 yrs, of those invited performed an acceptable
spirometry. Reasons for loss to follow-up have been
described in detail previously.14
Data collection
The study included extensive questionnaires and clinical
examinations. Respiratory symptoms (cough and dyspnea),
exposure of occupational dust and gas, educational level
and smoking habits were registered using self-administered
questionnaires. Occupational dust and gas exposure were
defined as an affirmative answer to the question “Have you
ever had a work place with much dust or gas in the air?”.
Smoking habits were classified as never smokers, current
smokers and ex-smokers. One pack-year was defined as 20
cigarettes a day for 1 year. Educational level was classified
into primary, secondary and university. Height and weight
were registered, and body mass index (BMI) was calculated
based on WHO guidelines.
FVC and FEV1 were measured according to the American
Thoracic Society standards with a Vitalograph 2160
Table 1 Characteristics of study population by sex of
participants in the Hordaland County cohort study 2003e05,
N Z 1664 subjects aged 35e90 yrs.
Total Women Men p-Value#
Age yrs 54.7 (13) 55.1 (13) 54.3 (13) 0.21
Smoking habits <0.001
Never-smokers 618 (38) 343 (43) 275 (33)
Ex-smokers 532 (32) 221 (28) 311 (37)
Current smokers 491 (30) 234 (29) 257 (31)
Pack-years for
ever-smokers
<0.001
1e9 373 (37) 200 (44) 173 (31)
10e19 303 (30) 140 (31) 163 (29)
20þ 342 (34) 112 (25) 230 (41)
Body mass
index (kg/m2)
<0.001
<18.5 23 (1) 18 (2) 5 (1)
18.5e24.9 808 (49) 452 (56) 356 (42)
25e29.9 624 (38) 238 (30) 386 (45)
>30 193 (12) 93 (12) 100 (12)
Educational
level
0.85
Primary 242 (15) 114 (14) 128 (15)
Secondary 945 (57) 461 (57) 484 (57)
University 476 (28) 235 (29) 241 (28)
Occupational
exposure to
gas or dust
<0.001
Yes 710 (43) 211 (26) 499 (59)
No 935 (57) 589 (74) 346 (41)
Total 1664 811 853
Data are presented as mean  SD (continuous variables) and n
(%) (categorical variables). #: p-values are from the two-group
mean comparison test (unpaired t-test) for continuous vari-
ables and Chi-squared tests for categorical variables.
Information on smoking habits was missing for 13 females and 10
males. Information on pack years was missing for 16 females
and 12 males. Information on BMI was missing for 10 females
and 6 males. Information on educational level was missing for 1
female. Information on occupational dust exposure was missing
for 11 females and 8 males.
Increased COPD prevalence in Norway 1039spirometer (Vitalograph Ltd, Maids Moreton, UK) before and
after inhalation of a total of 0.4 mg salbutamol powder. In
the previous study phase in 1996e97, a Gould 2100
spirometer was used, and 0.3 mg salbutamol was adminis-
tered.20 The study engineers were trained by experienced
personnel in both study phases. COPD was defined accord-
ing to the GOLD guidelines as post-bronchodilator FEV1/FVC
<0.7 for the main analyses.2 In addition, we also analysed
COPD in 2003e05 defined as FEV1/FVC < lower limit of
normal, using recent European reference equations 25
Informed consent was obtained from each participant.
The study was approved by The Regional Committee of
Medical Research Ethics (Bergen, Norway).
Statistical analyses
All analyses were performed using Stata 12 (StataCorp. LP,
College Station, TX). P-values below 0.05 were considered
statistical significant. Prevalence of GOLD-defined COPD
was calculated using mean estimations with 95% confidence
intervals. Logistic regression analysis were used to evaluate
the association between a number of potential risk factors
of COPD (sex, age, smoking habits, pack-years, BMI,
educational level and occupational exposure) and COPD.
Significant variables in the univariate analysis were
included in the multivariate model. Attributable fractions
(PAF) were calculated using the Stata command punaf with
95% confidence intervals.
We tested for interactions between sex and all the other
potential risk factors for COPD in separate analyses.
Results
Characteristics of the study population are presented in
Table 1. Mean age was 55 yrs for women and 54 yrs for men.
There was a significant gender difference in smoking habits,
pack-years, BMI and occupational exposure to dust and gas.
Characteristics of the 1996/97 study population are pre-
sented in the Online Supplement, E-Table 1.
The prevalence of GOLD defined COPD was 13.7%, an
increase of almost 7% compared with the prevalence in the
previous study phase, 1996e7 (Table 2).
There was a higher prevalence of COPD among men than
women, 17% and 11%, respectively. However, the preva-
lence of COPD among women had increased by 175%
compared with 1996e97. When COPD was defined by GOLD
stages, the prevalence was highest in GOLD stage I and II for
both men and women (Fig. 2). The prevalence increased
with increasing age and pack-years, and decreased with
higher educational level. Approximately 1 out of 4 over 65
years suffered from COPD, but only 1 out of 20 under 50
years. Not surprisingly, never-smokers had a lower preva-
lence of COPD than ever-smokers. While approximately 1
out of 20 never-smokers had COPD, as many as 1 out of 5
current smokers suffered from COPD. The prevalence of
COPD was higher in the underweight group than in the
obese group, and higher amongst the subjects who had
been exposed to occupational dust and gas than among
unexposed, 16% and 12%, respectively.
Proportions of respiratory symptoms in spirometry-
defined COPD cases are presented in Fig. 3. Men reportedhigher prevalence of all types of cough, whereas women
reported higher prevalence of dyspnea and attacks of dys-
pnea. However, the differences were not statistically sig-
nificant. Approximately 70% of both men and women with
COPD experienced one or more symptoms. Only 24% of the
GOLD-defined COPD subjects had a physician’s diagnosis.
The unadjusted OR showed that sex, age, smoking
habits, pack-years, educational level and occupational
exposure were significantly associated with COPD (see
Online Supplement E-Table 3).
Adjusted odds ratios (OR) for COPD, of both 1996e7 and
2003e05, are presented in Table 3. After adjustment for
other significant covariates, subjects older than 65 yrs had
10 times higher odds for COPD than subjects younger than
50 yrs. Current smokers had 5 times higher odds for COPD
than never smokers, and those with more than 20 pack-
years had 4 times higher odds for COPD than subjects
Table 2 Prevalence estimates with 95% confidence intervals (CI) of GOLD-defined COPD (post-bronchodilator FEV1/FVC<0.7)
in a general adult population in 1996e97 and 2003e05 by sex, age, smoking habits, pack years, body mass index, educational
level and occupational exposure to dust or gas. N Z 2235 subjects aged 27e82 yrs in 1996e97 and N Z 1664 subjects aged
35e90 yrs in 2003e05.
Prevalence (%) 1996e7 (95% CI) Prevalence (%) 2003e5 (95% CI) Increase (%)
Sex Women 4 (3, 5) 11 (8, 13) 175
Men 10 (9, 12) 17 (14, 19) 70
Age (yrs) 34 yrs 2 (0, 3) e e
35e49 yrs 3 (2, 4) 5 (3, 7) 67
50e64 yrs 6 (4, 8) 14 (11, 16) 133
65 yrs 20 (17, 24) 28 (24, 33) 40
Smoking habits Never-smokers 3 (2, 4) 7 (5, 8) 133
Ex-smokers 11 (9, 14) 16 (13, 19) 45
Current
smokers
9 (7, 11) 20 (16, 23) 122
Pack-yrs for
ever-smokers
1e9 5 (3, 7) 8 (5, 11) 60
10e19 9 (6, 12) 16 (11, 20) 78
20þ 17 (14, 21) 31 (26, 36) 82
BMI <18.5 13 (0, 27) 17 (2, 33) 31
18.5e24.9 8 (6, 10) 15 (12, 17) 88
25e29.9 6 (4, 8) 13 (10, 16) 117
>30 6 (3, 8) 12 (7, 17) 100
Educational
level
Primary 14 (11, 18) 23 (17, 28) 64
Secondary 6 (5, 7) 14 (12, 17) 133
University 3 (2, 5) 8 (5, 10) 167
Occupational Yes 9 (7, 11) 16 (13, 18) 78
Exposure No 5 (4, 6) 12 (10, 14) 140
Total 7 (6, 8) 14 (12, 15) 100
1040 M. Waatevik et al.with under 10 pack-years. However, educational level and
occupational exposure were not significantly associated
with GOLD-defined COPD in the multivariate analysis. When
comparing the results from the present study with corre-
sponding results from the previous study phase, the effectFigure 2 Prevalence of COPD defined by GOLD stages in a ge
35e90 yrs.of age on COPD risk is the same in the two time periods.
However, the effect of male gender and educational level
after adjustment for other risk factors has decreased.
Heavy smokers with more than 20 pack years had a higher
OR for COPD in the present study than in 1996e97, whileneral adult population in 2003e05. N Z 1664 subjects aged
Figure 3 Prevalence of respiratory symptoms in a general adult population in 2003e05. N Z 1664 subjects aged 35e90 yrs.
Increased COPD prevalence in Norway 1041ex-smokers had a markedly lower OR for COPD in 2003e05
than in 1996e97.
There was not found any significant interactions be-
tween sex and any of the other potential risk factors for
COPD. Hence, no stratification for sex was made in the
multivariate analyses.
Table 4 presents adjusted population attributable frac-
tions (PAF) with 95% confidence intervals for both 1996/97Table 3 Adjusted odds ratios (OR) with 95% confidence interva
general adult population in 1996e97 and 2003e05, by sex, age, sm
exposure. N Z 2235 subjects aged 27e82 yrs in 1996e97 and N Z
Adjusted
Sex Women 1
Men 3.1 (2.1,
Age (yrs) 35e49 yrs 1
50e64 yrs 2.4 (1.3,
65 yrs 10.9 (6.4,
Smoking habits Never-smokers 1
Ex-smokers 3.6 (2.1,
Current smokers 4.2 (2.4,
Pack-years for
ever-smokers
1e9 1
10e19 1.6 (0.9,
20þ 2.7 (1.5,
Educational level Primary 2.6 (1.4,
Secondary 1.5 (0.8,
University 1
Occupational Yes 1.2 (0.8,
Exposure No 1
Covariates were all significant in univariate analyses, and are adjusteand 2003e05 study phases. 74% of COPD among current
smokers can be attributed to smoking in 2003e05, which
was approximately the same in the previous study phase.
32% of COPD among men can be attributed to male gender
in 2003e05, a decline from the previous study phase were
55% of COPD among men was attributed to male gender.
We also analysed COPD defined as <LLN in 2003e05
(E-Tables 2 and 4). Overall prevalence according to thisls (95%CI) for COPD (post-bronchodilator FEV1/FVC<0.7) in a
oking habits, pack years, educational level and occupational
1664 subjects aged 35e90 yrs in 2003e05.
OR 1996e97 (95%CI) Adjusted OR 2003e05 (95%CI)
1
4.8) 1.7 (1.2, 2.3)
1
4.2) 3.3 (2.2, 5.2)
18.6) 10.3 (6.4, 16.5)
1
6.2) 2.4 (1.6, 3.6)
7.5) 5.2 (3.3, 8.1)
1
3.1) 2.3 (1.4, 3.8)
4.9) 4.2 (2.6, 6.7)
5.3) 1.5 (0.9, 2.4)
2.7) 1.4 (0.9, 2.1)
1
1.8) 1.1 (0.8, 1.5)
1
d for each other in the multivariate models.
Table 4 Adjusted population attributable fractions (PAF)
with 95% confidence intervals (95%CI) for COPD (post-bron-
chodilator FEV1/FVC < 0.7) in a general adult population in
1996e97 and 2003e05, by sex, age, smoking habits, pack
years, educational level and occupational exposure.
NZ 2235 subjects aged 27e82 yrs in 1996e97 and NZ 1664
subjects aged 35e90 yrs in 2003e05.
Adjusted PAF
1996e97
(95%CI)
Adjusted PAF
2003e05
(95%CI)
Sex Women Ref Ref
Men 55% (35%, 69%) 32% (12%, 47%)
Age (yrs) 35e49 yrs Ref Ref
50e64 yrs 55% (24%, 73%) 65% (49%, 77%)
65 yrs 87% (79%, 92%) 85% (78%, 90%)
Smoking
habits
Never-
smokers
Ref Ref
Ex-smokers 63% (39%, 77%) 50% (29%, 65%)
Current
smokers
75% (59%, 85%) 74% (62%, 82%)
Pack-years
for ever-
smokers
1e9 Ref Ref
10e19 33% (11%, 59%) 49% (21%, 66%)
20þ 53% (26%, 70%) 66% (50%, 76%)
Educational
level
Primary 47% (9%, 69%) 23% (11%, 47%)
Secondary 16% (42%, 51%) 24% (6%, 45%)
University Ref Ref
Occupational Yes 14% (18%, 37%) 4% (23%, 25%)
Exposure No Ref Ref
1042 M. Waatevik et al.definition was 8.7%. Compared with GOLD-defined COPD,
LLN-defined COPD were more pronounced among the
youngest age group, and less prevalent among men and
participants over 65 yrs. ORs for risk factors were compa-
rable regardless of COPD definition, apart from for age and
male gender, which affected GOLD-defined COPD substan-
tially more than LLN-defined COPD.Discussion
The updated Norwegian prevalence estimate of spirometry-
defined COPD is approximately 14%, twice as high as eight
years earlier. The risk factors for COPD remain the same
over time, but the strengths of the associations vary. While
educational level and male gender had less effect on COPD
prevalence in 2005 than in 1997, pack years were more
important in 2005 than in 1997. Almost one out of three
ever-smokers with more than 20 pack years suffers from
COPD according to the present study. Three in four COPD
cases among current smokers were due to smoking. The
degree of under diagnosis is substantial. Less than 1 out of 5
of the GOLD defined COPD cases in this study has a relevant
clinical diagnosis, even though a vast majority of them re-
ports one or more respiratory symptoms.
The present study defined COPD according to post-
bronchodilator spirometry. We also analysed the preva-
lence of pre bronchodilator test FEV1/FVC < 0.7 (results
not shown). The overall prevalence was 21%, which is 7%
higher than the results of the post bronchodilator test.Johannessen et al.20 investigated this in more detail for the
previous study phase in 1996/97 and found similar results.
Especially more young never smokers would be included as
COPD cases when using pre bronchodilator prevalence
results.
The prevalence estimate from the present study is in
accordance with other recent prevalence studies of
spirometry-defined COPD, such as the Burden of Obstruc-
tive Lung Disease study (BOLD).19 In Sweden, estimates
from the BOLD study indicated that 16% of the adult pop-
ulation suffered from COPD.26 A study from Copenhagen
indicated that Danish COPD prevalence exceeds 17%.27 A
report from the Northern Ireland Cost and Epidemiology of
Chronic Obstructive Pulmonary Disease (NICECOPD) study
stated that the prevalence of GOLD-defined COPD stage 2
or more severe was 6.3% in a general population aged
40e69 yrs.28 In our study, prevalence of GOLD-defined
COPD stage 2 or worse was 8.4% which is in accordance
with the NICECOPD estimates given the higher age range in
our study. Most other studies confirm that COPD prevalence
is increasing, although a recent Spanish study in fact re-
ported a decrease in COPD prevalence from 1997 to 2007.6
The results of this study is based only on the results of
lung function tests, and not including a thorough medical
examination as is appropriate when diagnosing COPD.
Therefore it could be argued that the use of COPD is not
appropriate. We have nevertheless chosen to use the COPD
term in this study because it is in line with international
guidelines and other epidemiology studies.
Since most other contemporary prevalence studies have
similar estimates as the present study, there is little reason
to believe that the current prevalence estimate is an over-
estimation. Consequently, the most striking with our results
is that GOLD-defined COPD prevalence is twice as high as
the prevalence estimate that has been in used in Norway
until now; 14% versus 7%.20 There are several plausible
explanations for this large discrepancy.
Firstly, there is a substantial age difference in the two
study populations. The study population is basically the
same in the two studies. The age range was 26e82 yrs in the
former study, while it was 35e90 yrs in the latter. Since
COPD is closely related to age and is very rare among sub-
jects below 40 yrs of age, the population is more proper for
COPD estimates in the second than in the first follow-up.
From this perspective, the present COPD estimate is likely
to be more realistic than the previous Norwegian COPD
estimate.
To examine if the differences in Norwegian prevalence
estimates from 7% in the first HCCS follow-up to 14% in the
second follow-up is in fact a result of an ageing study
population, we compared COPD prevalence in the two time
periods across population characteristics such as gender,
age groups, smoking habits and educational level, as
mentioned in the results from Table 2. The prevalence was
higher across all categories in 2003e05 when compared
with 1996e97, even across age categories. Also, when
estimating the COPD prevalence within the same age range
(35e82 yrs) in the two time periods, additional analyses
showed that COPD prevalence in 1996e97 was 8.2% and
COPD prevalence in 2003e05 was 13% (results not shown).
These estimates suggest that the higher COPD prevalence
estimates in the present study compared to the previous
Increased COPD prevalence in Norway 1043Norwegian prevalence study reflect an actual increase in
prevalence, and that it is not only due to different age
structure in the population.
An explanation for the increased prevalence compared
to earlier estimates could be methodological. The present
study is the second follow-up of the Hordaland County
Cohort Study, and the same cohort has been followed for as
much as 20 years. Although this is considered a substantial
strength of the study in many contexts, it could be viewed
as a limitation in the present study since we focus on cross-
sectional disease prevalence in a general population. Loss
to follow-up could potentially bias the estimates. However,
a previous report showed that loss to follow-up in the
present study was not associated with baseline lung func-
tion, age, height, occupational exposure to airborne agents
or smoking habits. Only low socioeconomic status was a
predictor for non-response in this study.14 To check if the
participants in our study in 2003e05 were a less healthy
sample than the participants in the previous study phase in
1996e97, we also compared the 1996 COPD prevalence for
all participants within the age range 35e82 yrs with the
1996 COPD prevalence for only those participants within
the age range 35e82 yrs who also participated in the
follow-up in 2003. Total 1996 prevalence in the age range
35e82 yrs was 8.2% (95% CI 6.9, 9.4) while 1996 prevalence
for those who also participated in the follow-up was actu-
ally lower: 5.2% (95% CI 3.9, 6.4) (results not shown). We
therefore do not find it likely that the study population in
the second HCCS follow-up was systematically less healthy
than the study population in the first HCCS follow-up.
The risk for COPD increased with increasing pack years
at both time points but more so in the present study than in
1996. At the same time ex-smokers had higher OR for COPD
in 1996 than in 2005. This should be viewed in light of COPD
being the result of cumulative exposures over a long time
period and the fact that it is a disease with a long latency
period. Even if smoking prevalence is now declining in
Norway it will still take some decades before this decline is
mirrored in a lower COPD prevalence. The result regarding
ex-smokers, however, indicates that improvement has
started: although the prevalence of COPD among ex-
smokers is higher in 2005 than in 1996, the adjusted risk
for COPD as measured in odds ratios is lower in 2005 than in
1996. In addition, the general ageing of the world’s popu-
lation leads to an independent increase in COPD; both since
age in itself is a risk factor for COPD, and since a longer
lifetime gives the individual a longer period of time to be
cumulatively exposed to various risk factors.29
Numerous epidemiological studies on COPD and
obstructive airways symptoms have found that low educa-
tional level is an independent risk factor for developing this
disease.13,30e33 In the present study, we found a clear
tendency for increasing COPD with decreasing educational
level with the prevalence estimates ranging from 5% among
those with university education to 17% among those with
compulsory education only. However, this tendency was
only statistically significant in univariate model (Online
Supplement, E-Table 3) and not in the multivariate
model. A further inspection of the data showed that the
association between educational level and COPD lost sta-
tistical significance after adjustment for smoking habits.
Substantially more smokers had lower education, andsubstantially more never-smokers had accomplished uni-
versity education. In the present study, the effect of edu-
cation on COPD was thus confounded by smoking habits.
This is particularly interesting since the study of the same
population 8 years earlier showed a significant association
between COPD and education also after adjustment for
smoking. Further investigations will be needed to disen-
tangle why education is no longer an independent predictor
for COPD in an ageing study population.
The use of fixed ratio criterion (postbronchodilator
FEV1/FVC < 0.7) to define COPD has received much criti-
cism during the last years. It has been shown that using such
a fixed cut-off results in an underestimation of COPD among
younger subjects and an overestimation of COPD among the
elderly.34e37 There is a growing international consensus
that FEV1/FVC < lower limit of normal (LLN) should be used
to define COPD in epidemiological studies, to help over-
come the problems associated with a fixed cut-off.21e23 To
further investigate the COPD prevalence in the general
Norwegian population of the present study, we performed
additional analysis of LLN-defined COPD prevalence (E-
Table 2 and 4). The analysis was based on European refer-
ence equations from the Swiss LuftiBus study,25 and gave a
COPD prevalence of 8.7%. This prevalence reduction is in
accordance with what others have found. A report from the
Swedish part of the BOLD study stated that prevalence
decreased from 16% to 10% when changing the fixed cut-off
with the lower limit of normal.26 Furthermore, we found
that ORs for increasing age and male gender were the most
dependent on COPD definition, both being strongest asso-
ciated with GOLD-defined COPD.
The large amount of under diagnosis in COPD remains a
fact whatever spirometric definition one chooses to
implement.4e7 In the present study, only one out of five
men and one out of three women with GOLD-defined COPD
had a relevant physician’s diagnosis. When examining LLN-
defined COPD, on the other hand, 1 out of 4 men with COPD
had a relevant physician’s diagnosis, while the proportion
for women was the same as with GOLD-defined COPD. At
the same time, a vast majority of them e more than 70% of
subjects with GOLD-defined COPD e reported being
affected by respiratory symptoms. Respiratory symptoms
are important for predicting long-term clinical outcomes in
COPD,38 and thus under diagnosis among symptomatic
subjects is very unfortunate. We still have a long way to go
before COPD is properly diagnosed in a primary care
setting. A better routine for diagnosing COPD and increased
COPD awareness among primary care physicians could
greatly improve patient management, since early detection
and treatment of COPD patients are of the utmost impor-
tance for enhanced lifespan and quality of life in this group
of patients.
To conclude, the present study has shown that preva-
lence of GOLD-defined COPD is 14%, a substantial increase
from the last prevalence study 8 years earlier. The risk
factors for disease remained the same, but strength of as-
sociations varied over time. Regardless, smoking is still the
most important risk factor, approximately every third ever-
smoker with more than 20 pack-years suffered from COPD.
Only a small minority of the COPD subjects had a relevant
diagnosis, although a vast majority of them reported res-
piratory symptoms.
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